REGENERATIVE MEDICINE AND STEM CELL THERAPEUTICS

Pharmacology and Therapeutics: Principles to Practice

Volumn , Issue , 2008, Pages 1317-1331

  J Nelson, Timothy ^a   Behfar, Atta ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85158931536     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3291-5.50098-6     Document Type: Chapter

References (68)

1. SA Waldman, MR Terzic and A Terzic (2007) Molecular medicine hones therapeutic arts to science. Clin Pharmacol Ther 82 343-347.
2. GQ Daley and DT Scadden (2008) Prospects for stem cell-based therapy. Cell 132 544-548.
3. N Rosenthal (2003) Prometheus's vulture and the stem-cell promise. N Engl J Med 349 267-274.
4. I Klimanskaya, N Rosenthal and R Lanza (2008) Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 7 131-142.
5. SJ Morrison and AC Spradling (2008) Stem cells and niches: mechanisms that promote stem cell mainteneance throughout life. Cell 132 598-611.
6. A Atala (2008) Advances in tissue and organ replacement. Curr Stem Cell Res Ther 3 21-31.
7. M Kørbling and Z Estrov (2003) Adult stem cells for tissue repair—a new therapeutic concept? N Engl J Med 349 570-582.
8. MA Surani and A McLaren (2006) Stem cells: a new route to rejuvenation. Nature 443 284-285.
9. JA Shizuru, RS Negrin and IL Weissman (2005) Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56 509-538.
10. J Rossant (2008) Stem cells and early lineage development. Cell 132 527-531.
11. JA Thomson, J Itskovitz-Eldor, SS Shapiro, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282 1145-1147.
12. D Solter (2006) From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat Rev Genet 7 319-327.
13. J Silva and A Smith (2008) Capturing pluripotency. Cell 132 532-536.
14. A Behfar, C Perez-Terzic, RS Faustino, et al. (2007) Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 204 405-420.
15. CE Murry and G Keller (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132 661-680.
16. CA Koch, P Geraldes and JL Platt (2008) Immunosuppression by embryonic stem cells. Stem Cells 26 89-98.
17. S Goldman (2005) Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23 862-871.
18. E Kroon, LA Martinson, K Kadoya, et al. (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26 443-452.
19. MA Laflamme and CE Murry (2005) Regenerating the heart. Nat Biotechnol 23 845-856.
20. D Fraidenraich and R Benezra (2006) Embryonic stem cells prevent developmental cardiac defects in mice. Nat Clin Pract Cardiovasc Med 3(Suppl 1), S14-S17.
21. C Van de Ven, D Collins, MB Bradley, et al. (2007) The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol 35 1753-1765.
22. CP McGuckin and N Forraz (2008) Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif 41(Suppl 1), 31-40.
23. P De Coppi, G Bartsch Jr, MM Siddiqui, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25 100-106.
24. AJ Wagers and IL Weissman (2004) Plasticity of adult stem cells. Cell 116 639-648.
25. SH Orkin and LI Zon (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132 631-644.
26. G Chamberlain, J Fox, B Ashton and J Middleton (2007) Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 2739-2749.
27. DG Phinney and DJ Prockop (2007) Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Stem Cells 25 2896-2902.
28. AL Caplan (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213 341-347.
29. C Martinez, TJ Hofmann, R Marino, et al. (2007) Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 109 4245-4248.
30. K Le Blanc and O Ringdén (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262 509-525.
31. R Jaenisch and R Young (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132 567-582.
32. X Yang, SL Smith, XC Tian, et al. (2007) Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 39 295-302.
33. M Nakagawa, M Koyanagi, K Tanabe, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26 101-106.
34. IH Park, R Zhao, JA West, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 141-146.
35. SA Waldman, NB Christensen, JE Moore and A Terzic (2007) Clinical pharmacology: the science of therapeutics. Clin Pharmacol Ther 81 3-6.
36. Committee for Medicinal Products for Human Use (2007) Guideline on Human Cell-Based Medicinal Products (EMEA/CHMP/410869/2006) London: European Medicines Agency 1-24.
37. DG Halme and DA Kessler (2006) FDA regulation of stem-cell-based therapies. N Engl J Med 355 1730-1735.
38. E Copelan (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354 1813-1826.
39. T Hahn, SN Wolff, M Czuczman, et al. (2001) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review. Biol Blood Marrow Transplant 7 308-331.
40. T Hahn, JR Wingard, KC Anderson, et al. (2003) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biol Blood Marrow Transplant 9 4-37.
41. T Hahn, D Wall, B Camitta, et al. (2005) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 11 823-861.
42. T Hahn, D Wall, B Camitta, et al. (2006) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 12 1-30.
43. DM Oliansky, JD Rizzo, PD Aplan, et al. (2007) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 13 1-25.
44. D Baksh, L Song and RS Tuan (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8 301-316.
45. AI Caplan (2005) Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11 1198-1211.
46. M Krampera, G Pizzolo, G Aprili and M Franchini (2006) Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39 678-683.
47. B Soria, FJ Bedoya, JR Tejedo, et al. (2008) Cell therapy for diabetes mellitus: an opportunity for stem cells? Cells Tissues Organs 188 70-77.
48. RP Robertson (2004) Islet transplantation as a treatment for diabetes. N Engl J Med 350 694-705.
49. AM Shapiro, JR Lakey, EA Ryan, et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 230-238.
50. AM Shapiro, C Ricordi, BJ Hering, et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355 1318-1330.
51. P Anversa and B Nadal-Ginard (2002) Myocyte renewal and ventricular remodelling. Nature 415 240-243.
52. A Leri, J Kajstura, P Anversa and WH Frishman (2008) Myocardial regeneration and stem cell repair. Curr Probl Cardiol 33 91-153.
53. S Dimmeler, AM Zeiher and MD Schneider (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 572-583.
54. VF Segers and RT Lee (2008) Stem-cell therapy for cardiac disease. Nature 451 937-942.
55. P Menasché, AA Hagège, M Scorsin, et al. (2001) Myoblast transplantation for heart failure. Lancet 357 279-280.
56. SR Opie and N Dib (2006) Surgical and catheter delivery of autologous myoblasts in patients with congestive heart failure. Nat Clin Pract Cardiovasc Med 3(Suppl 1), S42-S55.
57. AA Hagège, JP Marolleau, JT Vilquin, et al. (2006) Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114(Suppl I), I108-I113.
58. P Menasché, O Alfieri, S Janssens, et al. (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 1189-1200.
59. V Schächinger, B Assmus, MB Britten, et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 1690-1699.
60. PL Sánchez, JA San Román, A Villa, et al. (2006) Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 3(Suppl 1), S138-S151.
61. H Drexler, GP Meyer and KC Wollert (2006) Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial. Nat Clin Pract Cardiovasc Med 3(Suppl 1), S65-S68.
62. K Lunde, S Solheim, S Aakhus, et al. (2007) Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 154 710.e1-710.e8.
63. V Schächinger, S Erbs, A Elsässer, et al., for the REPAIR-AMI Investigators (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 1210-1221.
64. S Janssens, C Dubois, J Bogaert, et al. (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 113-121.
65. EC Perin, HF Dohmann, R Borojevic, et al. (2004) Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110(Suppl II), II213-II218.
66. J Bartunek, M Vanderheyden, W Wijns, et al. (2007) Bone-marrow-derived cells for cardiac stem cell therapy: safe or still under scrutiny? Nat Clin Pract Cardiovasc Med 4(Suppl 1), S100-S105.
67. A Abdel-Latif, R Bolli, IM Tleyjeh, et al. (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 989-997.
68. A Atala (2006) Recent applications of regenerative medicine to urologic structures and related tissues. Curr Opin Urol 16 305-309.